Andrew DelaCourt
YOU?
Author Swipe
View article: Spatial omics-based machine learning algorithms for the early detection of hepatocellular carcinoma
Spatial omics-based machine learning algorithms for the early detection of hepatocellular carcinoma Open
In conclusion, we present the development and application of a new biomarker platform, which can identify effective biomarkers for the early detection of HCC. This platform may also apply to other diseases, in which changes in N-linked gly…
View article: The Spatial Extracellular Proteomic Tumor Microenvironment Distinguishes Molecular Subtypes of Hepatocellular Carcinoma
The Spatial Extracellular Proteomic Tumor Microenvironment Distinguishes Molecular Subtypes of Hepatocellular Carcinoma Open
Hepatocellular carcinoma (HCC) mortality rates continue to increase faster than those of other cancer types due to high heterogeneity, which limits diagnosis and treatment. Pathological and molecular subtyping have identified that HCC tumo…
View article: Supplementary Table ST2 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma
Supplementary Table ST2 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma Open
Lists individual N-glycans, ALT (Alanine transaminase), AST (aspartate aminotransferase), ALK (Alkaline phosphatase), and AFP (Alpha-fetoprotein) of analysis to differentiate patients with iCCA from PSC. 1Possible biomarkers 2n: number of …
View article: Supplementary Figure SF4 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma
Supplementary Figure SF4 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma Open
A. Scatterplots and correlations between N-glycans of interest (1339, 1257, 2158) and clinical information available (ALT, AST, ALK, and AFP). B. Multivariate model-Multiple logistic regression in CCA and PSC serum samples (n=40). Model 1:…
View article: Supplementary Table ST2 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma
Supplementary Table ST2 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma Open
Lists individual N-glycans, ALT (Alanine transaminase), AST (aspartate aminotransferase), ALK (Alkaline phosphatase), and AFP (Alpha-fetoprotein) of analysis to differentiate patients with iCCA from PSC. 1Possible biomarkers 2n: number of …
View article: Supplementary Table ST1 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma
Supplementary Table ST1 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma Open
Peak list of N-glycans detected in tissue (TMA) and serum samples.
View article: Supplementary Figure SF3 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma
Supplementary Figure SF3 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma Open
A. Relative contribution of each serum-glycan (left) and TMA-glycan (right) in the first and second principal components. The size and color of the circle represent a higher contribution of the glycan to the respective Dim. (Dimension). B.…
View article: Supplementary Figure SF2 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma
Supplementary Figure SF2 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma Open
Patient demographics for A. TMA 1 and B. TMA 2. C. Patient demographics for serum cohort. ALT (Alanine transaminase), AST (aspartate aminotransferase), AFP (Alpha-fetoprotein), and ALP (Alkaline phosphatase). Other liver diseases include n…
View article: Data from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma
Data from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma Open
There is an urgent need for the identification of reliable prognostic biomarkers for patients with intrahepatic cholangiocarcinoma (iCCA) and alterations in N-glycosylation have demonstrated an immense potential to be used as diagnostic st…
View article: Supplementary Figure SF4 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma
Supplementary Figure SF4 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma Open
A. Scatterplots and correlations between N-glycans of interest (1339, 1257, 2158) and clinical information available (ALT, AST, ALK, and AFP). B. Multivariate model-Multiple logistic regression in CCA and PSC serum samples (n=40). Model 1:…
View article: Supplementary Figure SF3 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma
Supplementary Figure SF3 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma Open
A. Relative contribution of each serum-glycan (left) and TMA-glycan (right) in the first and second principal components. The size and color of the circle represent a higher contribution of the glycan to the respective Dim. (Dimension). B.…
View article: Supplementary Figure SF1 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma
Supplementary Figure SF1 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma Open
Hematoxylin & Eosin (H&E) staining of A. Intrahepatic Cholangiocarcinoma (iCCA) tissue, 10x (right) and 40x (left) magnification images from respective areas of the tissue, and B. Hepatocellular Carcinoma (HCC) tissue, 10x magnification im…
View article: Supplementary Figure SF2 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma
Supplementary Figure SF2 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma Open
Patient demographics for A. TMA 1 and B. TMA 2. C. Patient demographics for serum cohort. ALT (Alanine transaminase), AST (aspartate aminotransferase), AFP (Alpha-fetoprotein), and ALP (Alkaline phosphatase). Other liver diseases include n…
View article: Data from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma
Data from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma Open
There is an urgent need for the identification of reliable prognostic biomarkers for patients with intrahepatic cholangiocarcinoma (iCCA) and alterations in N-glycosylation have demonstrated an immense potential to be used as diagnostic st…
View article: Supplementary Figure SF5 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma
Supplementary Figure SF5 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma Open
Relative intensity quantification of all N-glycans identified in serum (left row) and tissue (right row) analysis. Red font labeling for N-glycans follows the same trend between serum and tissue.
View article: Supplementary Figure SF5 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma
Supplementary Figure SF5 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma Open
Relative intensity quantification of all N-glycans identified in serum (left row) and tissue (right row) analysis. Red font labeling for N-glycans follows the same trend between serum and tissue.
View article: Supplementary Figure SF1 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma
Supplementary Figure SF1 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma Open
Hematoxylin & Eosin (H&E) staining of A. Intrahepatic Cholangiocarcinoma (iCCA) tissue, 10x (right) and 40x (left) magnification images from respective areas of the tissue, and B. Hepatocellular Carcinoma (HCC) tissue, 10x magnification im…
View article: Supplementary Table ST1 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma
Supplementary Table ST1 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma Open
Peak list of N-glycans detected in tissue (TMA) and serum samples.
View article: Table S1 from N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes
Table S1 from N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes Open
Patient Characteristics Table
View article: Figure S2 from N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes
Figure S2 from N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes Open
An overview of how HCC samples are classified into one of three subtypes based upon a variety of histological, clinical, and genetic data. Genetic data is generated through RNA-seq of the HCC samples.
View article: Table S4 from N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes
Table S4 from N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes Open
N-glycan structures increased in non-tumor tissue cores compared to tumor tissue cores in the tissue micro-array
View article: Table S2 from N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes
Table S2 from N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes Open
Full list of glycans analyzed on the FT-ICR mass spectrometer.
View article: Table S1 from N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes
Table S1 from N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes Open
Patient Characteristics Table
View article: Data from N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes
Data from N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes Open
Hepatocellular carcinoma (HCC) is the second leading cause of cancer deaths globally, and the incidence rate in the United States is increasing. Studies have identified inter- and intratumor heterogeneity as histologic and/or molecular sub…
View article: Figure S2 from N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes
Figure S2 from N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes Open
An overview of how HCC samples are classified into one of three subtypes based upon a variety of histological, clinical, and genetic data. Genetic data is generated through RNA-seq of the HCC samples.
View article: Data from N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes
Data from N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes Open
Hepatocellular carcinoma (HCC) is the second leading cause of cancer deaths globally, and the incidence rate in the United States is increasing. Studies have identified inter- and intratumor heterogeneity as histologic and/or molecular sub…
View article: Table S2 from N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes
Table S2 from N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes Open
Full list of glycans analyzed on the FT-ICR mass spectrometer.
View article: Table S3 from N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes
Table S3 from N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes Open
Full list of glycans analyzed on the MALDI-TOF mass spectrometer
View article: Table S4 from N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes
Table S4 from N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes Open
N-glycan structures increased in non-tumor tissue cores compared to tumor tissue cores in the tissue micro-array
View article: Table S3 from N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes
Table S3 from N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes Open
Full list of glycans analyzed on the MALDI-TOF mass spectrometer